If you are genuinely interested in PAA then you should go and read the terms of the trials as picking out the word "exploratory" and determining phase 2 results based on that is too simplistic a view. Considering Phase 1 was all about determining safety there has already been substantive clinical information.
Phase 1 looked at patients that had failed all standards of care so not newly diagnosed and happy to be corrected but from my memory phase 2 will not be newly diagnosed patients but again patients that have already been through treatment and have exhausted options.
Possible breakout, page-21
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
0.003(1.43%) |
Mkt cap ! $86.33M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.8¢ | $30.60K | 170.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 161511 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 197928 | 5 |
View Market Depth
| Last trade - 11.55am 12/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |